Cargando…
Relationship between non-alcoholic fatty liver disease and coronary heart disease
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and considered a liver manifestation of metabolic syndrome. It is in close relationship with insulin resistance, obesity, diabetes mellitus, all of which increase risk of cardiovascular disease (CVD). Besides, ma...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642538/ https://www.ncbi.nlm.nih.gov/pubmed/33195636 http://dx.doi.org/10.12998/wjcc.v8.i20.4688 |
_version_ | 1783606108774989824 |
---|---|
author | Arslan, Ugur Yenerçağ, Mustafa |
author_facet | Arslan, Ugur Yenerçağ, Mustafa |
author_sort | Arslan, Ugur |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and considered a liver manifestation of metabolic syndrome. It is in close relationship with insulin resistance, obesity, diabetes mellitus, all of which increase risk of cardiovascular disease (CVD). Besides, many studies point out that NAFLD independently contributes to the development of atherosclerosis and CHD. On the other hand, CVDs are the leading cause of death in NAFLD patients. Many pathophysiological changes and molecular mechanisms play an important role in NAFLD for CVD formation. Atherosclerosis is common in NAFLD, which also mainly contributes to the CVD formation and CHD. Many studies linking atherosclerotic CHD and NAFLD are present in the literature. Subclinical CHD, mainly detected by coronary computed tomography views, have been detected more common in NAFLD patients. Presence of NAFLD has been found to be more common in patients with severe CHD and in stable CHD, NAFLD has been found to be associated with more diffuse disease. In acute coronary syndromes, especially in acute myocardial infarction, patients with NAFLD have been found to have poor prognosis when compared with NAFLD free patients. In this review, our aim is to evaluate the relationship between NAFLD and CHD in detail and go over the pathophysiological mechanisms underlying this relationship. |
format | Online Article Text |
id | pubmed-7642538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-76425382020-11-13 Relationship between non-alcoholic fatty liver disease and coronary heart disease Arslan, Ugur Yenerçağ, Mustafa World J Clin Cases Minireviews Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and considered a liver manifestation of metabolic syndrome. It is in close relationship with insulin resistance, obesity, diabetes mellitus, all of which increase risk of cardiovascular disease (CVD). Besides, many studies point out that NAFLD independently contributes to the development of atherosclerosis and CHD. On the other hand, CVDs are the leading cause of death in NAFLD patients. Many pathophysiological changes and molecular mechanisms play an important role in NAFLD for CVD formation. Atherosclerosis is common in NAFLD, which also mainly contributes to the CVD formation and CHD. Many studies linking atherosclerotic CHD and NAFLD are present in the literature. Subclinical CHD, mainly detected by coronary computed tomography views, have been detected more common in NAFLD patients. Presence of NAFLD has been found to be more common in patients with severe CHD and in stable CHD, NAFLD has been found to be associated with more diffuse disease. In acute coronary syndromes, especially in acute myocardial infarction, patients with NAFLD have been found to have poor prognosis when compared with NAFLD free patients. In this review, our aim is to evaluate the relationship between NAFLD and CHD in detail and go over the pathophysiological mechanisms underlying this relationship. Baishideng Publishing Group Inc 2020-10-26 2020-10-26 /pmc/articles/PMC7642538/ /pubmed/33195636 http://dx.doi.org/10.12998/wjcc.v8.i20.4688 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Arslan, Ugur Yenerçağ, Mustafa Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title | Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title_full | Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title_fullStr | Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title_full_unstemmed | Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title_short | Relationship between non-alcoholic fatty liver disease and coronary heart disease |
title_sort | relationship between non-alcoholic fatty liver disease and coronary heart disease |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642538/ https://www.ncbi.nlm.nih.gov/pubmed/33195636 http://dx.doi.org/10.12998/wjcc.v8.i20.4688 |
work_keys_str_mv | AT arslanugur relationshipbetweennonalcoholicfattyliverdiseaseandcoronaryheartdisease AT yenercagmustafa relationshipbetweennonalcoholicfattyliverdiseaseandcoronaryheartdisease |